
Honest, plain-English answers on what peptides are and whether they actually work, from BPC-157 and GHK-Cu to the weight loss peptides everyone is asking about, Retatrutide versus the GLP-1s semaglutide and tirzepatide. Every claim sourced, every guide routes to your doctor, never around one, and every guide leaves you better informed.
Everyone knows Ozempic and Wegovy. Almost nobody explains the medicine. Our plain-English guide breaks down how GLP-1 drugs actually work, injection versus pill, the real side effects, and how to protect your muscle and metabolic health. No hype, no sales pitch.
No affiliate sales codes, no sponsored placements. What you read is what we found in the research.
We are clear about which is which, and where the evidence gets thin or runs out entirely.
No hype, no molecule worship. Just what is known, what is not, and what to ask your doctor.
New, plain-English, evidence-first writing every week on the peptides people are asking about.
HormonesAs the Department of War screens troops 30+ for testosterone, here are the actual options, TRT vs peptide signaling, explained straight.
8 min read
Weight LossEveryone knows the names. Almost nobody understands the medicine. Semaglutide, tirzepatide, retatrutide, injection vs pill, told straight.
9 min read
EvidenceA plain look at the animal and human studies, the benefits, side effects, and where they stop.
7 min readWhat the advisory committee vote does, and does not, mean.
6 min readSample size, controls, and why animal results do not always carry over.
9 min readHow to bring peptides up with a provider, and what to want answered.
5 min read
LegalThree legal lanes, the 2026 reclassification, and the July FDA hearing that could change access. Plain English.
11 min readSeparating the cosmetic evidence from the marketing.
6 min readWhy "research use only" is a legal shield, not a safety guarantee, and how to spot a real source.
8 min readTwelve peptides came off the FDA's restricted list in April 2026. Now the advisory committee decides, in stages, whether any earn a legal compounding pathway. This is one milestone on a long road, not the finish. We track every step, and we tell you plainly what it does and does not mean.
Ahead of the vote, the FDA's own briefing documents recommend against adding all seven, citing incomplete characterization, little or no human efficacy data, and unresolved immunogenicity concerns. Each status below is a forecast until the committee votes. The moment it does, we flip each one to the real outcome and link the source.







A second PCAC meeting is scheduled before the end of February 2027 for the remaining peptides taken off the restricted list, and GHK-Cu gets its own separate evaluation. The FDA has not posted briefing documents or an exact date for these yet, so there is no forecast to give. We track them here and update the moment there is real news.






Deep, plain-English guides across recovery, performance, longevity, and beauty. New titles added every week.
Founding readers: your discount is applied automatically, no code needed.
The most-studied recovery peptide. Strong animal data on healing and repair, with human evidence still catching up.
Founding price, discount applied automatically
A tissue-repair peptide often discussed alongside BPC-157. What the research shows, and where it stops.
A peptide studied for gut health, inflammation, and barrier support. Under FDA review now. What the evidence shows, plainly.
A growth factor variant studied for muscle repair. The honest evidence picture, in plain English.
An immune-modulating peptide with real clinical history in specific uses. What is established and what is not.
An antimicrobial peptide the body makes itself. What researchers are actually studying it for.
A growth-hormone-releasing peptide. How it is studied, and the questions that remain.
Often paired with CJC-1295 in the literature. A plain look at the evidence and the caveats.
One of the older growth-hormone-releasing peptides, with a real clinical background. The honest summary.
Technically a compound, not a peptide, but grouped here for how it is used. What the human data says.
One of the few peptides here with FDA-approved use. What that approval covers, and what it does not.
A copper peptide popular in skin and hair products. What the cosmetic science actually supports.
Studied for pigmentation. A candid look at the evidence and the real safety questions.
A peptide tied to longevity research, mostly from a single research lineage. What to make of it, honestly.
A plain-English guide to the peptides most discussed in longevity circles, and what the evidence supports.
A growth-hormone fragment studied for fat metabolism. What early research showed, and its limits.
A mitochondrial-derived peptide studied for metabolism. The honest state of the evidence.
A nootropic peptide with a research history mostly outside the US. What is known and what is not.
Studied for anxiety and calm. A plain look at the evidence base and where it is thin.
Studied for memory, focus, and neuroplasticity. Under FDA review. What the evidence supports, and what it does not.
Delta sleep-inducing peptide. What the sleep research actually shows, without the hype.
Studied for sexual function, with an FDA-approved relative. The honest breakdown.
A combined guide to the peptides most discussed together for recovery and performance. Evidence-first, no hype.
A guide to the cognitive and calm peptides, examined together. What the research supports.
The peptides discussed for sleep and overnight recovery, in one honest guide.
A combined look at the peptides most talked about for longevity and preservation.
The repair and regeneration peptides, examined together with the real evidence.
A combined guide to the metabolic peptides. What is supported, and what is still open.